Welcome to our dedicated page for Texas Instrument SEC filings (Ticker: TXN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Texas Instruments Incorporated filings document operating results, governance actions, capital-structure details and material events for a Nasdaq-listed semiconductor company. Form 8-K reports cover quarterly and annual results, furnished earnings releases, non-GAAP free cash flow measures and related reconciliations, as well as dividend and shareholder-return disclosures.
Proxy and annual meeting filings describe board elections, executive compensation votes, auditor ratification and other stockholder proposals. Additional 8-K disclosures record by-law amendments, forum-selection provisions, officer transition matters, registered common stock details and exhibits filed in Inline XBRL.
Texas Instruments director Curtis C. Farmer received an award of 85.18 stock units on June 19, 2026 as director compensation. Each stock unit converts into one share of common stock and will be settled after he leaves the board. Following this award, he directly holds 2,911 shares of common stock and 2,143.97 stock units credited under the company’s 2018 Director Compensation Plan, including units from dividend reinvestment.
Texas Instruments director Pamela H. Patsley reported updated equity holdings. She received a grant of 85.18 stock units of Texas Instruments on June 19, 2026 at a reference price of $322.86 per unit under the Texas Instruments 2018 Director Compensation Plan. These stock units convert into common stock on a one-for-one basis and will be settled in common shares after her service as a director ends. Following this grant, she holds 34,487 shares of common stock directly and 65,169.89 stock units credited to her director compensation accounts, including units added through the plans’ dividend reinvestment features.
Texas Instruments Incorporated announced that its board has appointed Julie Knecht as senior vice president and Chief Financial Officer (and Chief Accounting Officer), effective August 1, 2026. She will succeed Rafael Lizardi, who is retiring after 25 years with the company.
The company states that Mr. Lizardi’s retirement is not related to financial or operating results, or to any disagreements about financial reporting or internal controls. In her new role, Ms. Knecht will receive an annual base salary of $700,000 and $2 million in restricted stock units as equity compensation.
TEXAS INSTRUMENTS INC director Martin S. Craighead sold a total of 10,000 shares of Common Stock in open-market transactions. The sales took place on May 28, 2026, in two trades of 357 and 9,643 shares.
The 357-share sale was executed at a weighted average price of $321.0069 per share, and the 9,643-share sale was executed at an average price of $320.4075 per share. A footnote explains that sale prices for one of the trades ranged from $320.00 to $320.9867 and that detailed price breakdowns are available on request. Following these transactions, Craighead continues to hold Common Stock directly.
Texas Instruments Inc. submitted a Form 144 notice dated 05/28/2026 for a proposed sale of 10,000 shares of Common Stock through RBC Capital Markets LLC on the NYSE. The filing lists an aggregate amount of $3,200,000.00 and CUSIP 910092791. The shares were acquired in two open-market purchases: 4,025 shares on 10/25/2018 and 5,975 shares on 01/28/2021.
Texas Instruments senior vice president Ahmad Bahai exercised stock options and sold shares on the same day. On May 14, 2026, he exercised a nonqualified stock option for 5,000 shares of common stock at $110.15 per share, then sold 5,000 shares in an open-market transaction at a weighted average price of $309.1272 per share. The sales occurred in a price range from $308.85 to $309.53. After these transactions, Bahai directly holds 42,519 shares of common stock and 16,534 stock options, which are scheduled to expire on January 25, 2028.
Texas Instruments Sr. Vice President & CFO Rafael R. Lizardi reported an option exercise and related stock sales. He exercised a nonqualified stock option to acquire 47,734 shares of common stock at a strike price of $174.81 per share, then sold 47,734 shares in open-market transactions. The reported sale prices include weighted-average prices of $307.8474, $308.5448, and $309.4487 per share, with footnotes noting price ranges around these levels. After these transactions, he holds 85,485 shares of Texas Instruments common stock directly and 33,994 shares indirectly through a SLAT.
Texas Instruments director Carrie Smith Cox exercised stock options and sold the resulting shares of common stock. She exercised options for 4,532 shares at $104.41 per share and 4,306 shares at $110.15 per share, then sold a total of 8,838 shares in open-market transactions around $306 per share. Following these transactions, she holds 37,626 shares of Texas Instruments common stock directly.
UBS Financial Services Inc. submitted a Form 144 notifying the sale of 47,734 shares of Common Stock of Texas Instruments (TXN), with the filing dated 05/14/2026. The notice lists cash as the consideration type and shows a recent reported sale of 40,541 shares on 04/24/2026.
This filing is a routine Rule 144 notice documenting an intended or effected sale by a broker/dealer; it lists broker addresses and sale dates but does not state proceeds or the ultimate purchaser.
Texas Instruments reported a Form 144 notifying proposed sales of Common Stock through UBS Financial Services Inc. The filing lists transactions linked to ESOP grants dated 01/25/2018 and 01/25/2019, with listed amounts 4,306 and 4,532 respectively and a filing date of 05/13/2026.